PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025

Understanding Critical Quality Attributes

With the increasing prominence of biopharmaceutical products in the modern therapeutic landscape, it has become vitally important to ensure the manufacture of these products is carried out reliably and efficiently. Therefore, the FDA introduced the concepts of quality by design (QbD) into the cGMP regulations in 2004. These guidelines provide the framework by which pharmaceutical companies can design their products, processes, and control procedures to ensure that a product has all the attributes considered paramount to its safety and efficacy –
the critical quality attributes (CQAs). Omar Musleh at SGS Life Sciences explores how to use these to develop a life-saving biologic.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/Understanding-critical-quality-attributes.pdf” width=”100%” height=”900px” style=”border:0;”]

 

Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Eppendorf – 18.03.2025